<DOC>
	<DOCNO>NCT01468883</DOCNO>
	<brief_summary>Patients biopsy proven breast cancer , clinical stage I II , randomize receive treatment one two method : ( 1 ) total mastectomy axillary dissection ; ( 2 ) excisional biopsy , axillary dissection , definitive irradiation . Data single institution retrospective comparison suggest definitive irradiation cosmetically acceptable breast preservation offer survival local control result equivalent extirpative surgery . This study test hypothesis prospective , randomized manner . After primary therapy , subject follow : ( 1 ) survival ; ( 2 ) sit recurrence ; ( 3 ) anatomic function ; ( 4 ) complication therapy ; ( 5 ) cosmesis .</brief_summary>
	<brief_title>The Treatment Stage I II Breast Cancer With Mastectomy Axillary Dissection vs. Excisional Biopsy , Axillary Dissection , Radiotherapy</brief_title>
	<detailed_description>Patients biopsy proven breast cancer , clinical stage I II , randomize receive treatment one two method : ( 1 ) total mastectomy axillary dissection ; ( 2 ) excisional biopsy , axillary dissection , definitive irradiation . Data single institution retrospective comparison suggest definitive irradiation cosmetically acceptable breast preservation offer survival local control result equivalent extirpative surgery . This study test hypothesis prospective , randomized manner . After primary therapy , subject follow : ( 1 ) survival ; ( 2 ) sit recurrence ; ( 3 ) anatomic function ; ( 4 ) complication therapy ; ( 5 ) cosmesis .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>INCLUSION CRITERIA : Female patient age dominant breast mass meeting follow requirement eligible protocol : On clinical evaluation tumor must confine breast axillary lymph node ( stage I II ) . Biopsy tumor must classify primary breast neoplasm epithelial origin . Patients must geographically accessible followup willing return followup NCI . Patient must mentally competent understand give inform consent protocol . EXCLUSION CRITERIA : Patients exclude protocol follow reason : Advanced local disease distant metastasis ( stage III IV ) ; Inflammatory cancer ; Chronic diseases heart , lung , liver , kidney , blood , metabolic disorder may render patient poor operative risk ; History another cancer skin cancer ( nonmelanoma ) ; Concurrent pregnancy lactation ; Nonpalpable lesion manifest nipple discharge skin rash ( Paget 's disease ) ; Previous therapy breast cancer excisional biopsy ; Multiple mass multiple suspicious area mammogram unless one proven histologically benign ; Bilateral breast carcinoma , either invasive insitu .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>November 18, 2016</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>Surgery</keyword>
	<keyword>Radiation</keyword>
</DOC>